Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis
Emre Bora
Psychological Medicine (2019) Vol. 49, Iss. 12, pp. 1971-1979
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Аnna Morozova, Yana Zorkina, Olga Abramova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 70
Brain-derived neurotrophic factor and mental disorders
Chin-Chuen Lin, Tiao‐Lai Huang
Biomedical Journal (2020) Vol. 43, Iss. 2, pp. 134-142
Open Access | Times Cited: 117
The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110668-110668
Closed Access | Times Cited: 68
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Rodrigo Nieto, Andrea Carrasco, Sebastián Corral, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 64
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
Manuel Morrens, C. Overloop, Violette Coppens, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3237-3246
Open Access | Times Cited: 52
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 39
Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions
Hayley F. North, Jason Bruggemann, Vanessa Cropley, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 4, pp. 595-607
Closed Access | Times Cited: 53
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1284-1292
Open Access | Times Cited: 32
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 30
Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 426-426
Open Access | Times Cited: 17
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Antón L. Martínez, José Brea, Sara Rico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9905-9905
Open Access | Times Cited: 34
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25
The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia
Xuan Wang, Xiaofang Chen, Xiaoni Guan, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
Seon-Hwa Baek, Honey Kim, Ju‐Wan Kim, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1137-1137
Open Access | Times Cited: 20
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Yafen Wang, Weicheng Meng, Zhixin Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorder
Toon Anton Willem Scheurink, Jenny Borkent, Shiral S. Gangadin, et al.
Brain and Behavior (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 11
The neutrophil-lymphocyte ratio in first-episode medication-naïve patients with schizophrenia: A 12-week longitudinal follow-up study
Xiaobing Lu, Qianqian Sun, Ling Wu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110959-110959
Closed Access | Times Cited: 4
Effects of Sulforaphane on Negative Symptoms and Cognitive Impairments in chronic Schizophrenia patients: A Randomized Double-Blind Trial
Haiyu Chen, Jinjun Lu, Tianxiang Zou, et al.
Journal of Psychiatric Research (2025)
Closed Access
Disturbed Functional Connectivity Between Anterior Default Mode and Sensory Processing Regions Is Linked to Peripheral Inflammatory Markers and Psychopathology in Schizophrenia
Emanuel Mlynek, Xiaolin Tan, Sarah E. Lammertz, et al.
Schizophrenia Bulletin (2025)
Closed Access
Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
Irfan Ullah, Hashir Ali Awan, Alifiya Aamir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13032-13032
Open Access | Times Cited: 24
Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study
Marta Garés-Caballer, Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 18
Associations between inflammatory marker profiles and neurocognitive functioning in people with schizophrenia and non-psychiatric comparison subjects
David H. Adamowicz, Paul D. Shilling, Barton W. Palmer, et al.
Journal of Psychiatric Research (2022) Vol. 149, pp. 106-113
Open Access | Times Cited: 17
The Association Between Dietary Inflammatory Index and Cognitive Performance in Older Adults Aged 60 Years and Older
Wenlei Song, Yijun Feng, Zonglin Gong, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top